Author:
Ebrahimzadeh Armin,Mohseni Shokouh,Safargar Mohammad,Mohtashamian Abbas,Niknam Sara,Bakhoda Mohammadreza,Afshari Sanaz,Jafari Amirhossein,Ebrahimzadeh Anahita,Fooladshekan Sara,Mohtashami Alireza,Ferns Gordon A.,Babajafari Siavash,Sohrabi Zahra
Reference67 articles.
1. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications;Fabbrini;Hepatology,2010
2. Role of liver biopsy in nonalcoholic fatty liver disease;Nalbantoglu;World J Gastroenterol: WJG,2014
3. Nonalcoholic fatty liver disease;Brunt;Nat Rev Dis Prim,2015
4. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial;Jazayeri-Tehrani;Nutr Metab,2019
5. Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial;Daneshi-Maskooni;Nutr Metab,2018
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献